SAVR an Option for Many Low-Risk Patients Excluded From Clinical Trials SAVR an Option for Many Low-Risk Patients Excluded From Clinical Trials
Many patients who are excluded from clinical trials comparing transcatheter aortic-valve replacement with surgical aortic-valve replacement appear to do well with the latter approach, according to researchers in Canada.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 20, 2021 Category: Surgery Tags: Cardiology News Source Type: news

Houston Methodist first in Houston to perform TriClip procedure
(Houston Methodist) Cardiologists at Houston Methodist recently performed the first catheter-based repair in Houston of a leaky tricuspid valve using the novel TriClip system. Using cardiac ultrasound guidance, doctors were able to implant two TriClip devices in a 75-year-old patient as part of the pivotal TRILUMINATE trial, which seeks to evaluate the safety and efficacy of the device. The tricuspid valve has traditionally required conventional open-heart surgery to repair or replace it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 13, 2021 Category: International Medicine & Public Health Source Type: news

Structural Valve Deterioration at 5 Years of TAVR Versus SAVR Structural Valve Deterioration at 5 Years of TAVR Versus SAVR
Does bioprosthetic valve failure occur more frequently with transcatheter aortic valve replacement compared with surgical replacement?Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

TAVR Volumes in the U.S. Have Risen Each Year Since 2011
THURSDAY, Nov. 19, 2020 -- The volume of transcatheter aortic valve replacement (TAVR) procedures in the United States increased from 2011 to 2019, exceeding surgical aortic valve replacements in 2019, and 30-day mortality and stroke rates have... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2020 Category: Pharmaceuticals Source Type: news

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need f...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Opioid epidemic leads to more, younger people having heart valve operations
ROCHESTER, Minn. ? The opioid epidemic in the U.S. is becoming a bigger problem medically, socially and financially, and the COVID-19 pandemic has made it worse, according to the Food and Drug Administration. Heart surgeons have seen a disturbing trend over the past decade: more and younger patients with infective endocarditis requiring heart surgery. Infective [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - October 28, 2020 Category: Hospital Management Source Type: news

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revasculariz...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Survival Rate of Heart Valve Replacement Surgery
Title: Survival Rate of Heart Valve Replacement SurgeryCategory: Diseases and ConditionsCreated: 10/23/2020 12:00:00 AMLast Editorial Review: 10/23/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 23, 2020 Category: Cardiology Source Type: news

Results from the REFLECT II Trial reported at TCT Connect
(Cardiovascular Research Foundation) The REFLECT II randomized clinical trial evaluating the safety and efficacy of a device designed to reduce cerebral embolization and ischemic stroke, complications of transcatheter aortic valve replacement (TAVR), found that the device met the primary safety endpoint compared to historical controls but did not demonstrate superiority of the device for the primary hierarchical efficacy endpoint. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 15, 2020 Category: International Medicine & Public Health Source Type: news

New bioprosthetic valve for TAVR fails to demonstrate non-inferiority
(Cardiovascular Research Foundation) In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 15, 2020 Category: International Medicine & Public Health Source Type: news

Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut(TM) TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients
Medtronic Also Begins Feasibility Study of Evolut TAVR System in Moderate and Asymptomatic Aortic Stenosis Patients DUBLIN, Oct. 14, 2020 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), a global leader in structural heart therapi... Devices, Interventional, Cardiology Medtronic, transcatheter aortic valve replacement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 14, 2020 Category: Pharmaceuticals Source Type: news

Outcomes Worse for Deferred Aortic Valve Replacement
FRIDAY, Oct. 2, 2020 -- For patients with symptomatic severe aortic stenosis, deferred aortic valve replacement (AVR) is associated with an increased risk for hospitalization for valve-related symptoms or worsening heart failure, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 2, 2020 Category: Pharmaceuticals Source Type: news

Patients deferred for transcatheter aortic valve replacement because of COVID-19
(JAMA Network) This single-center study of 77 patients describes the outcomes of patients with symptomatic severe aortic stenosis during the COVID-19 pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 30, 2020 Category: Infectious Diseases Source Type: news

Aortic valve replacement during COVID-19 pandemic
(JAMA Network) The outcomes associated with deferred compared with expedited aortic valve replacement in patients with severe aortic stenosis during the COVID-19 pandemic are evaluated in this observational study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 30, 2020 Category: Infectious Diseases Source Type: news

Valvular AFib Heightens Risk in TAVR Valvular AFib Heightens Risk in TAVR
Atrial fibrillation confers an increased risk for poor outcomes after transcatheter aortic valve replacement (TAVR), but it is not clear how the etiology of AFib influences post-TAVR outcomes.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 29, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

‘I Had Heart Surgery in the Middle of a Coronavirus Hot Spot’
Anxiety and uncertainty about the pandemic is leading some patients to delay surgery. But how safe is that when you have an aneurysm in your heart? (Source: NYT Health)
Source: NYT Health - September 22, 2020 Category: Consumer Health News Authors: Johnny Diaz Tags: Coronavirus (2019-nCoV) Surgery and Surgeons Hospitals Aneurysms Miami Beach (Fla) Florida New York City Covid-19 precautions valve sparing aortic root repair. Heart Quarantines Mount Sinai Medical Center aortic aneurysm Source Type: news

Abbott Receives CE Mark for Next-Generation MitraClip ™ Heart Valve Repair Device to Treat Mitral Regurgitation
- CE Mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology (Source: Abbott.com)
Source: Abbott.com - September 21, 2020 Category: Pharmaceuticals Source Type: news

Valve-in-valve TAVI in Failed Aortic Bioprosthetic Valves Valve-in-valve TAVI in Failed Aortic Bioprosthetic Valves
Transcatheter aortic valve-in-valve implantation seems a viable alternative to redo surgery in patients with failed bioprosthetic valves, but major concerns about long-term outcomes persist.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 26, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Transcatheter Tricuspid Valve Repair for Right Heart Failure Transcatheter Tricuspid Valve Repair for Right Heart Failure
Tricuspid valve regurgitation has long been understudied and undertreated, but new studies are advancing our understanding of transcatheter tricuspid valve edge-to-edge repair for right-sided HF.JACC: Heart Failure (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 21, 2020 Category: Surgery Tags: Cardiology Journal Article Source Type: news

What Is Transcatheter Aortic Valve Replacement (TAVR)?
Title: What Is Transcatheter Aortic Valve Replacement (TAVR)?Category: Procedures and TestsCreated: 7/29/2020 12:00:00 AMLast Editorial Review: 7/29/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 29, 2020 Category: Cardiology Source Type: news

Engineers find thinner tissues in replacement heart valves create problematic flutter
(Iowa State University) Iowa State and University of Texas engineers have developed high-fidelity computational models of replacement heart valves to examine the performance of biological tissues built into the valves. They found that thinner tissues can flap and flutter, which can damage the valves and even the blood that flows by. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 29, 2020 Category: International Medicine & Public Health Source Type: news

Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries
IRVINE, Calif., July 15, 2020 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received... Devices, Cardiology, Surgery, FDA Edwards Lifesciences, KONECT RESILIA, aortic valved conduit (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 15, 2020 Category: Pharmaceuticals Source Type: news

Coronavirus Shows the Dangers of Letting Market Forces Govern Health and Social Care
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Coronavirus Shows the Dangers of Letting Market Forces Govern Health and Social Care appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - July 15, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Source Type: news

New heart valve could transform open heart surgery for millions of patients globally
A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge. The team's latest in-vitro results, published in Biomaterials Science, suggest that the PoliValve could last for up to 25 years. (Source: University of Bristol news)
Source: University of Bristol news - June 29, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences, Institutes, Institutes, Bristol Heart Institute; Press Release Source Type: news

SAVR Following TAVR May Present Extra Risks SAVR Following TAVR May Present Extra Risks
Patients undergoing surgical aortic-valve replacement following problems with an initial transcatheter aortic-valve replacement appear to have particularly poor outcomes, according to a retrospective analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 19, 2020 Category: Surgery Tags: Cardiology News Source Type: news

4D Flow MRI is feasible during exercise
Cardiac 4D flow MRI can quantify blood flow in the ascending aorta and main...Read more on AuntMinnie.comRelated Reading: AI speeds up reconstruction of 4D flow MRI MRI finds gender differences even in healthy hearts Advances in imaging, AI make cardiac MRI more accessible 4D flow MRI, 3D printing improve congenital heart surgery Heart valve-tracking algorithm boosts viability of 4D MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 19, 2020 Category: Radiology Source Type: news

Cardiologist investigates why TAVR might not work for some heart patient
(University of Cincinnati) A University of Cincinnati physician-researcher hopes a better understanding of how platelets function might help determine why some patients aren't good candidates for a transcatheter aortic valve replacement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2020 Category: International Medicine & Public Health Source Type: news

PET/MRI shows inflammation link to mitral valve prolapse
Researchers using a hybrid PET/MRI scanner detected a link between degenerative...Read more on AuntMinnie.comRelated Reading: 4 core applications of cardiovascular 3D printing Cardiac ultrasound at bedside boosts disease diagnosis ACC: Echocardiography identifies patients for valve repair Right heart quantification awareness: Part 6 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 1, 2020 Category: Radiology Source Type: news

Outcomes Similar After TAVR in Bicuspid, Tricuspid Anatomy
WEDNESDAY, May 27, 2020 -- All-cause mortality and stroke are comparable at 30 days and one year after transcatheter aortic valve replacement (TAVR) among patients with bicuspid and tricuspid valve stenosis, according to a study published online May... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 27, 2020 Category: Pharmaceuticals Source Type: news

Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair
IRVINE, Calif., May 18, 2020 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has ... Devices, Interventional, Cardiology, Regulatory Edwards Lifesciences, PASCAL transcatheter valve, tricuspid regurgitation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2020 Category: Pharmaceuticals Source Type: news

What Is a Percutaneous Valve Replacement Procedure?
Title: What Is a Percutaneous Valve Replacement Procedure?Category: Procedures and TestsCreated: 5/14/2020 12:00:00 AMLast Editorial Review: 5/14/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 14, 2020 Category: Cardiology Source Type: news

How Dangerous Is Percutaneous Heart Valve Replacement Surgery?
Title: How Dangerous Is Percutaneous Heart Valve Replacement Surgery?Category: Procedures and TestsCreated: 5/14/2020 12:00:00 AMLast Editorial Review: 5/14/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 14, 2020 Category: Cardiology Source Type: news

Best Practices for Human-Centric Design of Medical Devices
Medical devices designed to accommodate human variability present a growing opportunity for the healthcare and life sciences industries. Historically, medicine has solved many of the “simple” issues first: how to fix a broken leg has been known for centuries! But today we have treatments that didn’t even exist a generation ago, such as the use of stents and replacement valves for heart disease. These devices address a more limited cohort of people and are most successful when designed to be patient-specific. The cohorts themselves must also be further defined to account...
Source: MDDI - May 5, 2020 Category: Medical Devices Authors: Kristian Debus Tags: Design Source Type: news

CT helps predict TAVR outcomes
Identifying fibrotic lung disease on CT before transcathetor aortic valve replacement...Read more on AuntMinnie.comRelated Reading: 4D CT sheds light on post-TAVR treatment strategies 3D printing technique improves heart valve sizing 3D-printed aortas could work well for TAVR 3D printing helps evaluate leaks after TAVR procedures CT better than echo for aortic annulus before TAVR (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 4, 2020 Category: Radiology Source Type: news

Medtech in a Minute: Another Deal Bites the Dust, Telemedicine Changes the Game, and More
Another Deal Bites the Dust Citing a negative market impact from COVID-19, Alphatec backed out of its agreement to acquire EOS Imaging. While the deal is no longer feasible as contemplated, Alphatec said it is open to a strategic collaboration, if EOS is willing. Earlier this month, Organovo killed a proposed merger with Tarveda Therapeutics, but not because of the pandemic. That decision was prompted by indecisive scientific data on Organovo's part. Telemedicine Is Changing the Diabetes Game Telemedicine is emerging as the hero technology during COVID-19. In the diabetes space, the technology is enabling new patient acces...
Source: MDDI - April 30, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Edwards Lifesciences Drops 2020 Revenue Guidance Due to COVID-19
While Edwards Lifesciences reported first-quarter sales growth of 14%, the structural heart company saw a steep drop in procedure volume in the last few weeks of the quarter due to COVID-19. "As you might expect, procedure volumes in March varied greatly by geography, even by hospital, as patients and providers turned their focus to the pandemic," CEO Mike Mussallem said during the company's first-quarter earnings call, according to a SeekingAlpha transcript. Mussallem said the company expects the impact of COVID-19 on its transcatheter aortic valve replacement (TAVR) sales to be most severe in the second quarter...
Source: MDDI - April 25, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

Catheter-Based Solution Being Developed to Treat Heart Valve Calcification
Pi-Cardia Ltd. has raised $27 million to develop a catheter-based solution to treat heart valve calcification. The Rehovot, Israel-based company said the financing was led by Sonfinnova Partners and joined by Professor Jacques Séguin, Chairman of the company, with further participation from existing investors. The financing follows the successful completion of the company’s First-In-Human studies of the Leaflex Catheter. Pi-Cardia said its technology performs mechanical scoring of valve calcification, restoring leafelts’ mobility and improving valve hemodynamics. The company...
Source: MDDI - April 20, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Business Cardiovascular Source Type: news

PET/CT pinpoints Hodgkin's lymphoma treatment response
PET/CT significantly outperformed CT alone in predicting treatment response...Read more on AuntMinnie.comRelated Reading: FDG-PET leads prediction on neuroendocrine tumor outcomes IMV: PET scan volume continues growing at steady pace FDG-PET/CT points to cervical cancer patient outcomes FDG-PET/CT within a year of heart valve surgery looks safe PET/CT beats SPECT for neuroendocrine tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 20, 2020 Category: Radiology Source Type: news

Low-Risk TAVR Loses Ground at 2 Years in PARTNER 3 Low-Risk TAVR Loses Ground at 2 Years in PARTNER 3
Transcatheter aortic valve replacement (TAVR) continued to show superiority over surgical replacement at 2 years'follow-up, but between-group differences narrowed considerably.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 16, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Abbott's TriClip(TM) Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
CE Mark for TriClip represents an important treatment option for people with severe tricuspid regurgitation, a difficult-to-manage heart condition New system offers a proven safe and effective minimally invasive non-surgical solution The TriClip Syst... Devices, Interventional, Cardiology, Regulatory Abbott, TriClip, Transcatheter, Tricuspid Valve Repair, Tricuspid Valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2020 Category: Pharmaceuticals Source Type: news

Abbott's TriClip ™ Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
- CE Mark for TriClip represents an important treatment option for people with severe tricuspid regurgitation, a difficult-to-manage heart condition (Source: Abbott.com)
Source: Abbott.com - April 9, 2020 Category: Pharmaceuticals Source Type: news

TAVR equivalent to surgery at 2 years among low-risk patients
(American College of Cardiology) Patients undergoing transcatheter aortic valve replacement (TAVR) fared equally well compared with those undergoing open heart valve replacement surgery in terms of the combined risk of death, stroke or rehospitalization at two years, the primary endpoint of the PARTNER 3 trial being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

Antiplatelet drugs increase risk for TAVR patients with atrial fibrillation
(American College of Cardiology) Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk of clotting-related complications compared to patients who took antiplatelet medication in addition to oral anticoagulants, in a trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

TAVR shows favorable safety in patients with bicuspid valve
(American College of Cardiology) Transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days in patients with a bicuspid, or two-leaflet, aortic valve, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

Study finds room for improvement in TAVR outcomes across US
(American College of Cardiology) Thirty-four medical centers, representing 11% of facilities that perform transcatheter aortic valve replacement (TAVR) in the U.S., saw worse than expected outcomes in terms of survival and quality of life among patients undergoing the procedure in an analysis presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

TAVR found non-inferior to surgery in broad patient population
(American College of Cardiology) Patients who underwent transcatheter aortic valve replacement (TAVR) did not have a higher rate of death at one year compared with those who had their heart valve replaced via open-heart surgery, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

Landmark Phase 3 VOYAGER PAD Study of XARELTO ® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefi...
Source: Johnson and Johnson - March 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news

Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav(TM) Delivery System for the Company's Portico(TM) Valve
New FlexNav™ delivery system improves control and delivery of the Portico™ TAVI valve even in complex clinical cases The minimally invasive Portico procedure allows doctors to treat severe aortic valve stenosis without invasive surgery Approval of th... Devices, Interventional, Cardiology, Regulatory Abbott, FlexNav, Portico, transcatheter, aortic valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 5, 2020 Category: Pharmaceuticals Source Type: news

3D printing improves accuracy of knee arthroplasty
A new technique that relies on 3D-printed surgical guides designed with CT...Read more on AuntMinnie.comRelated Reading: Can ultrasound, 3D printing deepen maternal-fetal bonds? Can 3D printing help optimize cardiac CT protocols? 3D printing may improve safety of upper GI surgery 3D-printed head customizes neurosurgery simulation 3D printing technique improves heart valve sizing (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 3, 2020 Category: Radiology Source Type: news